Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q1 2023 Earnings Conference Call May 10, 2023 9:00 AM ET
Company Participants
Alex Lobo - Stern Investor Relations
Kevin Boyle - Chief Executive Officer
Drew Deniger - Vice President of Research & Development
Mike Wong - Vice President of Finance
Abhi Srivastava - Vice President of Technical Operations
Conference Call Participants
Prakhar Agrawal - Cantor Fitzgerald
Thomas Flaten - Lake Street Capital Markets
Swayampakula Ramakanth - HCW
Operator
Good day and thank you for standing by. Welcome to the Alaunos Therapeutics First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Alex Lobo. Please go ahead.
Alex Lobo
Good morning. Earlier this morning, Alaunos issued a press release announcing financial results for the three months ended March 31, 2023. We encourage everyone to read today's press release as well as the Alaunos quarterly report on Form 10-Q for the quarter ended March 31, 2023, which was filed this morning with the SEC.
The company's press release and annual report will also be available one the Alaunos' website at alaunos.com. In addition, this conference call is being webcast through the Investor Relations section of the company's website, and will be archived there for future reference.
Please note that certain information discussed on today's call is covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Participants are cautioned that this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, May 10, 2023. Actual results could differ materially from those stated or implied by the forward-looking statements made today due to risks and uncertainties associated with the company's business.
Information on potential risks and uncertainties are set forth in our most recent public filings with the SEC at sec.gov. The company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this webcast, except as may be required by applicable securities law.
With me today are Kevin Boyle Senior, Chief Executive Officer; Drew Deniger, Vice President of Research and Development; and Mike Wong, Vice President of Finance. Abhi Srivastava, Vice President of Technical Operations will also be available for the Q&A session.